Kestra Medical Technologies, Ltd. SEC filings KMTS

Kestra Medical Technologies, Ltd. has 187 filings in SEC EDGAR's recent list, going back to Aug 25, 2021. Its latest annual report, Form ARS, was filed on Jul 28, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (results of operations). The company's fiscal year ends on April 30.

Kestra Medical Technologies, Ltd. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
144 Notice of proposed sale Nov 3, 2026 —
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
144 Notice of proposed sale Oct 29, 2026 —
144 Notice of proposed sale Oct 28, 2026 —
144 Notice of proposed sale Oct 27, 2026 —
144 Notice of proposed sale Oct 27, 2026 —
4 Insider transaction Oct 22, 2026 Oct 21, 2026
4 Insider transaction Oct 22, 2026 Oct 20, 2026
144 Notice of proposed sale Oct 21, 2026 —
144 Notice of proposed sale Oct 20, 2026 —
4 Insider transaction Oct 1, 2026 Sep 30, 2026
144 Notice of proposed sale Sep 30, 2026 —
4 Insider transaction Sep 23, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 21, 2026 —
10-Q Quarterly report Sep 14, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 14, 2026 Sep 14, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
4 Insider transaction Sep 10, 2026 Sep 9, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
4 Insider transaction Sep 10, 2026 Sep 8, 2026
8-K Current report
Shareholder vote results
Sep 10, 2026 Sep 9, 2026
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Aug 18, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 11, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 7, 2026 —
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
ARS Annual report to shareholders Jul 28, 2026 Apr 30, 2026
DEFA14A Additional proxy material Jul 28, 2026 —
DEF 14A Proxy statement Jul 28, 2026 Sep 9, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 15, 2026 —
10-K Annual report Jul 14, 2026 Apr 30, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt
Jul 14, 2026 Jul 10, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction May 18, 2026 May 15, 2026
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction Apr 16, 2026 Apr 15, 2026
144 Notice of proposed sale Apr 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 8, 2026 —
S-3ASR Automatic shelf registration Apr 1, 2026 —
4 Insider transaction Mar 30, 2026 Mar 26, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
S-8 Employee stock plan registration Mar 18, 2026 —
144 Notice of proposed sale Mar 17, 2026 —
10-Q Quarterly report Mar 17, 2026 Jan 31, 2026
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
4 Insider transaction Mar 12, 2026 Mar 11, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 15, 2026 —
4 Insider transaction Dec 31, 2025 Dec 29, 2025
4 Insider transaction Dec 31, 2025 Dec 29, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
10-Q Quarterly report Dec 11, 2025 Oct 31, 2025
8-K Current report
Results of operations
Dec 11, 2025 Dec 11, 2025
4 Insider transaction Dec 4, 2025 Dec 3, 2025
8-K Current report
Material agreement
Dec 4, 2025 Dec 2, 2025
424B4 Prospectus Dec 3, 2025 —
EFFECT Filing Dec 2, 2025 —
S-1MEF Filing Dec 2, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
S-1 Registration statement Dec 1, 2025 —
8-K Current report
Results of operations
Dec 1, 2025 Dec 1, 2025
3 Initial insider ownership Nov 10, 2025 Nov 3, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
DRS Filing Oct 29, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 7, 2025 —
4/A Filing Sep 15, 2025 Mar 7, 2025
4/A Filing Sep 15, 2025 Mar 7, 2025
10-Q Quarterly report Sep 12, 2025 Jul 31, 2025
8-K Current report
Results of operations
Sep 11, 2025 Sep 11, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Mar 7, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
3 Initial insider ownership Sep 8, 2025 Sep 3, 2025
8-K Current report
Shareholder vote results
Sep 4, 2025 Sep 3, 2025
4 Insider transaction Jul 24, 2025 Jul 24, 2025
ARS Annual report to shareholders Jul 22, 2025 Apr 30, 2025
DEFA14A Additional proxy material Jul 22, 2025 —
DEF 14A Proxy statement Jul 22, 2025 Sep 3, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
10-K Annual report Jul 17, 2025 Apr 30, 2025
8-K Current report
Results of operations
Jul 15, 2025 Jul 15, 2025
3 Initial insider ownership Jun 12, 2025 Jun 4, 2025
8-K Current report
Officer or director change
Jun 6, 2025 Jun 4, 2025
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report Apr 17, 2025 Jan 31, 2025
8-K Current report
Results of operations
Apr 14, 2025 Apr 14, 2025
S-8 Employee stock plan registration Mar 7, 2025 —
8-K Current report
Material agreement, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Mar 7, 2025 Mar 5, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
3 Initial insider ownership Mar 6, 2025 Mar 6, 2025
424B4 Prospectus Mar 6, 2025 —
CERT Filing Mar 6, 2025 —
8-A12B Filing Mar 6, 2025 —
EFFECT Filing Mar 5, 2025 —
S-1MEF Filing Mar 5, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
S-1/A Amended registration statement Mar 3, 2025 —
CORRESP Letter to the SEC Feb 27, 2025 —
S-1/A Amended registration statement Feb 26, 2025 —
S-1 Registration statement Feb 10, 2025 —
DRSLTR Filing Feb 4, 2025 —
DRS/A Filing Feb 4, 2025 —
UPLOAD Letter from the SEC Jan 29, 2025 —
DRSLTR Filing Jan 17, 2025 —
DRS/A Filing Jan 17, 2025 —
UPLOAD Letter from the SEC Jan 7, 2025 —
DRSLTR Filing Dec 11, 2024 —
DRS/A Filing Dec 11, 2024 —
UPLOAD Letter from the SEC Dec 8, 2021 —
DRSLTR Filing Nov 23, 2021 —
DRS/A Filing Nov 23, 2021 —
UPLOAD Letter from the SEC Sep 29, 2021 —
DRS Filing Aug 25, 2021 —

Showing 187 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
KMTS (Nasdaq)
Fiscal year ends
April 30
Incorporated in
Bermuda
Headquarters
Kirkland, WA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1877184

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.